[ad_1]
The S&P 500 is on course to post big gains for the first half of 2024, with its runup in the first six months of this year so far crushing the historical average, according to Bespoke Investment Group
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...